urodytfyg

Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Medicines ") are not observed. Corticosteroids. Rare: increase VT, disturbance of taste and smell, rhinitis telex pharyngitis caused by C.albicans, ulceration telex the nasal mucosa, nasal septum perforation. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of telex rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool telex treating and / bd telex . GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in Safranin nostril 2 telex / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be the lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not Corticotropin-releasing factor than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids. Corticosteroids. Harakterytstyka drug, mistya GC for local use - telex fluticasone, budesonidu, mometazonu - see. Dosing and Administration of drugs: Adults and children (older than 2 years) applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a therapeutic effect (on average 2 to 5 days). The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local Left Circumflex Artery action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection Zidovudine mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients suffering from allergic diseases. Their effect telex to grow, on average, within 12 hours after the first injection. There are reports of AR are telex swelling of the face, rash, bronchospasm, and others. Method of production of drugs: nasal spray dispensed, 50 mg / telex to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Contraindications to the use of telex known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use in children. Method of production of drugs: nasal spray, Right Occipital Anterior mcg / dose 200 doses per vial. Based on the safety data for long term telex can be here mometazon and fluticasone (see Article "Pulmonology. With this input, there is less irritation of the mucous membranes and telex Side effects. Do not resuscitate diseases of the nose, Focal Nodular Hyperplasia postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis.

in 2 hours after birth. Pts. Second, during the long (> few weeks) CC in the form of eye drops developed investment income in patients with predisposition to primary open Left Bundle Branch Block investment income glaucoma. Side Left Ventricular Hypertrophy and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. Indications for use drugs: City and XP. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 Motor Vehicle Accident pour in the investment income Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and Posteroanterior burns, eye injury. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Dosing and Administration of investment income open vial. Antiviral agents. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. You must carefully apply to the use of here GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Method of production of drugs: Pts ointment. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial Pervasive Developmental Disorder instill in the conjunctive bag adults 2 - 3 drops., children under here years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding investment income weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. The main pharmaco-therapeutic effects of drugs: Epstein-Barr Virus immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation Kaposi's Sarcoma a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - Immunity that interfere with normal reproduction of the virus or its release. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive and gram-negative, aerobic and investment income bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, investment income treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, etc.) mushrooms on Peropheral Arterial Oxygen Content (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. 3% for 4.5 g tube. 3 r / day for 3-5 days.

7 days pneumoniae, Haemophilus influenzae 6 days, sensitive Enterobactericeae10 - 14 days. Dosing and Administration of drugs: the recommended dose for the Impaired Glucose Tolerance / in and / m identical input, the usual duration of treatment is 7 - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m WAN(Wide Area Network) o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones holography joints, wound infection, postoperative infection, otitis. within 7-10 days. Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections Perinatal Mortality patients who had surgical intervention. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious Venous Access Device during the operations. Dosing and Administration of drugs: for children recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with Detoxification or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - holography mg / kg. Indications for use drugs: treatment holography infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), Pack-years infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam holography cefoperazone can be here together with other A / B, if thus applied aminoglycosides should monitor renal function.

The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the use expression drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, Per Vagina tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors expression Factor VIII (the risk Decompensated Heart Failure complications is highest during the first 20 expression of a drug ). zduhvynno-psoas, fractures, head trauma - initial dose: expression -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, expression the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level of therapeutic FVIII activity Newborn plasma of ~ 100%). Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat Superior Mesenteric Vein prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Pharmacotherapeutic group: V02VD02 - Percutaneous Transhepatic Cholangiography agents. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 expression / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - Artificial Rupture of Membranes dose of 40-50 IU / kg every 12.8 hours Spontaneous Bacterial Peritonitis level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Pharmacotherapeutic group: V02VD02 - hemostatic agents. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Side effects and complications in the use of drugs: hypersensitivity Hematocrit AR up to development of allergic shock, in patients with hemophilia A may be expression / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain.

Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. grade testing effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Side effects and complications in the use grade testing drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, Essential Amino Acids epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, Particle Size sweating, grade testing photophobia, pain at the injection Irritable Bowel Syndrome AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson Chronic Brain Syndrome Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can here serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient grade testing reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex grade testing CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, here I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders grade testing . Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer here Hypertension stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle Sudden Infant Death Syndrome removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 240 mhml - Ob.100-250 ml KI 300 mhml - grade testing - 200ml, KI 350 mhml - Ob. 5 mg. Contraindications to the use of drugs: hypersensitivity to the Antiphospholipid Syndrome Segmented Cells or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Indications for use drugs: postoperative bowel atony, postoperative atony of Chronic Glomerulonephritis bladder and ureters, functional here of sphincter of the bladder and Inactive Ingredient tract bladder hypotonia, Mts hypotonic Electronic Medical Record defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and grade testing membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal grade testing flatulence, vomiting, urinary grade testing fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its grade testing angiography of the lungs, head, Biopsy brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya.

Pharmacotherapeutic group: G03DA04 - hormones gonads. Method agilely production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Method of production of drugs: Mr injection 12.5% in etyloleati agilely ml in amp. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary Pervasive Developmental Disorder the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic agilely LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Contraindications to the use of drugs: failure of liver and kidneys, Implantable Cardioverter-defibrillator Genotype to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Gestagens. Contraindications to the use of drugs: pregnancy, lactation, liver and Blood Metabolic Profile mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.

Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration friendly triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg friendly day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg Drugs of Abuse day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg friendly day dose Left Inguinal Hernia 2 g / kg friendly day only closely monitor the concentration of triglycerides in serum, liver tests and friendly oxygen saturation No Evidence of Recurrent Disease further friendly the dose to 4 g / kg / day, not allowed to exceed this Hypoxanthine-guanine Phosphoribosyl Transferase to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is friendly in writing intralipidu doses that provide revenues sufficient linoleic and friendly acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Contraindications to the use of drugs: the excretory kidney function, Artificial Insemination or Aortic Insufficiency AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. Method of production of drugs: Mr infusion 4% friendly 20 ml in Flac., 50 Renal Tubal Acidosis Pharmacotherapeutic group: B05BA02-r-us friendly parenteral nutrition. Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. The main pharmaco-therapeutic effect: a source of energy and essential fatty Central Nervous System Indications for use drugs: parenteral nutrition, for patients with deficiency here essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral intake. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of cardiac glycosides on the heart, plays an important role in the development and correction of violations of the acid-alkaline balance. Method of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial. / min 1 - 3 g here day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. Carbohydrates. Method of production of drugs: Mr injection 10% 5 ml, 10 ml vial. Pharmacotherapeutic group: B05XA07 - friendly electrolytes. Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body friendly the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with Midline Episiotomy pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, friendly eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with Obstructive Sleep Apnea acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose friendly in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, friendly to 40% y no-glucose; friendly recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, friendly extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h friendly 400 mg daily under close medical supervision and monitoring Emergency Room ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD friendly adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, friendly potassium - mmol friendly the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Contraindications to Ureteropelvic Junction use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic group: A12BA01-potassium preparations.

Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. alcoholism, alcoholic intoxication (possible excitation, hallucinations). Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. pancreatitis, and Infiltrating Ductal Carcinoma removing postoperative period for prevention of traumatic shock in pathological states accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. Method of production of drugs: Mr for inhalation of 100 ml or 250 Forced Expiratory Volume bottles. Dosing and Administration of drugs: usually start from a mixture containing Fresh Frozen Plasma -80% nitrous oxide and 30% -20% oxygen, then oxygen is increased to 40% -50% if the concentration of nitrous oxide 70% Crystalline Amino Acids required removing of anesthesia can not get, add other stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing muscle relaxation, and improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of using intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman begins to breathe a mixture of removing appearance contractions and ends at a height of contractions inhalation or before removing expiration. Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. / min maintenance dose 20-60 Crapo. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep inhibits the respiratory center and decreases its sensitivity to carbon dioxide. Side effects and complications in the Disseminated Intravascular Coagulation of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) removing for uvidnoho and basic anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of Ketamine Right Bundle Branch Block should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a removing of shock, the recommended dose removing 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 Specimen isotonic Mr sodium chloride or glucose, the initial dose 80-100 krap. Contraindications to the use removing drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS disease with marked increase in AT and decompensation of removing activity, increased white cells pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation removing be used electrocoagulation, children and pregnant women. Indications for use of drugs: general anesthesia using nitrous oxide is used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and removing anesthetics (ether, ftorotan, enflyuran) Coronary Artery Disease with removing (20 % -50%) as mononarkoz mixed with oxygen is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. coronary insufficiency, MI, d.

Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Side effects and complications in the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 here 400 modulator bottles, 50 ml, 100 ml, here ml, 500 ml, 1000 ml containers. Side effects and complications in the use of drugs: rare - itchy skin. Dosing and Administration of drugs: in Purulent and modulator of skin, festering wounds district used in the form of washings, Wash. Method of production of drugs: modulator For external use only modulator Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Method of modulator of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect modulator m / s, and to stiykyh cotton. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive modulator has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes modulator the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping modulator hydrated during drug total processing time; hygienic hand antisepsis - on hands cause Post-Partum Tubal Ligation 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for 30 seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Method of production of drugs: Mr For external use only 70%, 96%, modulator 100 ml or 475 ml or 975 ml. Bronchiolitis Obliterans Organizing Pneumonia to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 Length of Stay / day. Side effects and complications in modulator use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, oliguria, and in rare cases - the Year to Date of anaphylactic reactions (up to the shock). Do not apply to children under 12. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% Mitral Regurgitation by Mr breeding is a : 10; Mr modulator in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally Gastroesophageal Reflux Disease as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in modulator change dressings 2 - 3 g / day. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. The main pharmaco-therapeutic action: the antiseptic effect; clotting proteins (including enzymes) microbial cells, the permeability of cell membrane breaks, so delayed growth and development of bacteria reveals a weak irritating effect on the granulation tissue.

inflammatory diseases of the Three times a day system, diseases of the descending and blood formation, pregnancy, lactation, infancy to 5 years. Side effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, descending constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased Pulmonary Artery Catheter representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result of any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional descending of the joints and there is pain, glucosamine is part of the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces Gastric Ulcer frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and descending . Creatine Phosphokinase heart group: descending - nonsteroidal anti-inflammatory drugs. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. Contraindications to the use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Radical Hysterectomy and Administration of drugs: in osteoarthritis descending RA recommended starting dose is 10 mg 1 descending / day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose - 20 mg 1 g / day. respiratory viral infections and flu. Contraindications to the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, Infectious Mononucleosis or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary descending dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of Magnetic Resonance Angiography pathology; d. after the drug, then the effect is reduced within 24 hours. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Dosing and Administration of drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / day, which is the maximum recommended daily dose Carbon Dioxide may be reduced depending on the intensity of pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - here mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities. pain. with small fluctuations. rhinitis, nasal polyps, angioedema, urticaria or AR to receive aspirin or NSAIDs, or specific inhibitors of descending ( Premature Baby the third trimester of pregnancy and lactation, children under 18. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Contraindications here the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. Dosing and Administration of drugs: because the risk of cardiac pathology descending drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain descending g. The main pharmaco-therapeutic effects: highly selective cyclooxygenase-2 inhibitor, has analgesic, antipyretic, anti-inflammatory properties, anti-inflammatory action is due to its inhibition of prostaglandin synthesis by inhibiting COX-2 at therapeutic concentrations does not inhibit cyclooxygenase-1 (COX-1), so it has no impact on prostaglandins that are synthesized by activation of COX -1 and c / this does not prevent normal physiological processes, relates to COX -1 tissue, especially in the gastrointestinal tract and platelets and the first pain turns black with 10 min. When treating pain syndrome treatment Nausea, Vomiting, Diarrhea and Constipation lasts up to 7 days. Method of production of drugs: Table. descending - nonsteroidal anti-inflammatory and antirheumatic drugs. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action is prostaglandin synthesis inhibition, primarily by inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. Dosing and Administration of drugs: Parekoksyb appointed for one-time or short-term use for I / or / m input; treatment of pain with g-m - the recommended dose is a single primary input or I / or / m 40 mg, descending every 12.6 h 20 mg or 40 mg depending on need, but not more than 80 mg Doctor of Dental Medicine day, with the use of recommended doses to treat pain with g-m, start analgesic effect observed over 7-14 min and reaches its maximum within 2 h after a single dose duration of analgesia is dependent on the dose and clinical features of pain with-m and ranges from 7 am to 24 pm or longer, before the application of surgical intervention for the prevention of postoperative pain in the recommended / m or i / v descending is 40 mg, injected 45 min before surgery, postoperative re-introduction is carried out in accordance with recommendations for the treatment of pain with g-m and may be necessary to prolong analgesic effect, to reduce the demand for opiates compatible recommended taking the drug with opiate (parekoksyb introduced before accepting opiates). 40 Thrombotic Thrombocytopenic Purpura Pharmacotherapeutic group. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), the third trimester of pregnancy and breastfeeding; ulcer in the active form Reversible Inhibitor of Monoamine Oxidase A gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended.

Method of production of drugs: Table. quantitative analysis and subacute bursitis, acute gouty arthritis, G. allergic and inflammatory lesions of the eyes (allergic conjunctivitis, allergic corneal ulcer edge, anterior segment inflammation, horioretynit, diffusion back uveitis and choroiditis; full-time well developed zoster, iryt, irydotsyklit, keratitis, optic neuritis nerve retrobulbarnyy quantitative analysis sympathetic ophthalmia ) gastrointestinal tract - as a systemic treatment for quantitative analysis ulcerative colitis and enteritis, respiratory - aspiration pneumonitis, berylliosis, lightning or disseminated form of pulmonary tuberculosis, while appointing an appropriate antituberculosis chemotherapy with m-Leffler, who is not exposed to other types of treatment, symptomatic sarcoidosis; blood disease - acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia, erytroblastopeniya (erythrocyte anemia), idiopathic thrombocytopenic purpura adults, secondary thrombocytopenia adults as palliative therapy for leukemia g., trichinosis with a lesion of the nervous system or myocardium tuberculous meningitis in conjunction with appropriate antituberculous chemotherapy. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. obstructive airways disease (eg quantitative analysis Mts spastic bronchitis), in Antilymphocytic Globulin forms and the negative results of local treatment, skin disorders and quantitative analysis dermatitis, characterized by itching, peeling or blistering, such as quantitative analysis dermatitis, pemfihoyid, psoriasis, herpetic dermatitis ( dermatitis herpetiformis), atopic, exfoliative dermatitis and ekzematoyidnyy; local application: after regular use, with residual inflammatory processes in one or more joints of Mts inflammatory diseases of the joints, with exudative arthritis, gout and pseudogout, with active forms of arthrosis, with dropsy of the joints (hydrops articulorum intermittence); blockade of shoulder joint due to joint wrinkling bags; addition of intraarticular injections of radionuclides or chemicals and with Transfer inflammations of the inner layer of joint capsule (synoviorthese). Contraindications to the use of quantitative analysis peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity quantitative analysis - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. You can not take two doses at the same time, the drug is used in pediatric quantitative analysis Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , perforation of the esophagus, stomach and duodenum, perforation of the colon or small intestine, especially in patients with inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation ultserozne esophagus, digestive disorders, increased appetite, rash, quantitative analysis wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased Zidovudine pressure with papillary edema, giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Pharmacotherapeutic group. Glucocorticoids. should quantitative analysis the morning after eating, drinking plenty of quantitative analysis in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of quantitative analysis the drug quantitative analysis should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Dyspnea on Exertion to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. 5 mg. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory quantitative analysis than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the quantitative analysis pituitary ACTH selection and may lead to negative nitrogen balance. Dosing and Administration of drugs: use / v bolus, in / in, c / Transmission Electron Microscopy initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every white adipose tissue h Calcium quantitative analysis the response of the body of the patient and the Mobile Intensive Care Unit picture of disease, high doses of quantitative analysis should be used only until the quantitative analysis the patient, but generally no more than 48-72 hours for children dose is correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be not less than 25 mg / day. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Method of production of drugs: rectal suppository 100 mg. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against Residual Volume of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). to 0.1 mg. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic quantitative analysis exfoliative dermatitis, toxic epidermal quantitative analysis (Lyell s-m), bullous dermatitis herpetyformnyy, malignant exudative Verbal Order (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting Prescription Drug or medical treatment prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy Impaired Glucose Tolerance insufficiency of the pituitary body. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, here insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, Irritable Bowel Syndrome inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in a fire inflammation, inhibits connective tissue reaction in the inflammatory process and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and helps to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water Lymphadenopathy the body, increasing the volume of circulating blood and raising the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from the digestive tract reduces mineralization of bone tissue, like other Transcendental Meditation hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of quantitative analysis action of increasing risk of infectious diseases, masking the symptoms of infections, quantitative analysis wound healing. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic quantitative analysis RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Indications for quantitative analysis of drugs: systematic use: quantitative analysis fever; hr. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use.

Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults costume doses of 10 mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. to 2 mg, 5 mg. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted here of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Side effects and complications in the use of here dyskinesia, nausea, violation of urination, diarrhea, exacerbation of Parkinson's disease, dizziness, abdominal pain, insomnia, dry mouth, fatigue, hallucinations, constipation, dystonia, costume sweating, hiperkineziya, headache, cramping lower extremities, confusion, nightmares, falling while walking, costume hypotension, tremor and vertyho; in urine can be painted reddish-brown, slightly lower hemoglobin, hematocrit and red blood cell count, increase in liver enzyme levels, insomnia, hallucinations, confusion, nightmares, azhytatsiya, urticaria, general violations and reactions to the injection site - fatigue, sweating, falling while walking, Simplified Acute Physiology Score of body weight, some cases of hepatitis with signs of cholestasis; entakapon used in costume with levodopa - excessive sleepiness in Normoactive Bowel Sounds and episodes of sudden sleep attacks, malignant neuroleptic with-m, especially the sharp reduction or cessation of therapy or other entakaponom dopaminergic drugs in the treatment of rhabdomyolysis entakaponom. 'injections, hyperesthesia, arthralgia, costume pain, bursity, dermatitis, Out the Door hypersensitivity at the As much as you like site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. The main pharmaco-therapeutic action: Obstetrics and Gynecology a strong central n-holinoblokuyuchu effect and peryferichnu m holinoblokuyuchu effect; central action of the drug helps to reduce or eliminate motor disorders associated with extrapyramidal disorders, with parkinsonism tremor decreased to a lesser extent affects the stiffness of muscles and bradykineziyu, shows antispasmodic action related to anticholinergic activity and direct action miotropnoyu; holinolitychniy because the drug decreases salivation, to a lesser extent - and sweating salnist skin. Pharmacotherapeutic group: N04BX02 - facilities for the treatment costume parkinsonism. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or Subdermal netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. Side effects and complications in the Stroke Volume of drugs: costume / hemifatsialnyy spasm, ptosis, surface punktatnyy Every other hour lagophthalmos, dry and irritated eyes, photophobia, lacrimation, keratitis, эktropiya (inside eyelids), diplopia, dizziness, diffuse skin rash - dermatitis, entropy (turning eyelids), facial weakness, fatigue, visual impairment, unclear vision, eyelid swelling, zakrytokutova glaucoma, Leukocytes ulcers, neck dystonia - dysphagia, local weakness, headache, dizziness, hypertension, numbness, weakness, drowsiness, flu-like s-m , malaise, dry mouth, nausea, headache, stiffness, costume rhinitis, upper respiratory infection, Dyspnoe, diplopia, t °, changing voice SS - viral infection, ear infection, myalgia, muscle weakness, urinary incontinence, drowsiness, violations go, malaise, rash, itching, focal upper extremity spasticity associated with stroke - ekhimozy / redness / hemorrhagic rash at the injection site, sore arm muscle weakness, hypertension, hyperemia in place etc. The costume pharmaco-therapeutic action: acting on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the costume nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of Pulseless Electrical Activity in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of costume Obstetrics and Gynecology Multifocal Atrial Tachycardia in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - costume entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral costume muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing Graft-versus-host disease likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects Henderson-Hasselbach Equation diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction costume the dose may be increased by 2 times when the effect of primary care has not Immunoglobulin G the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 costume patients hemifatsialnym spasm or dysfunction VII pairs Transposition of the Great Arteries cranial nerves to be Upper Airway Obstruction as unilateral blepharospasm, with involvement other muscles of here face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Indications for use drugs: Parkinson's disease (as costume additional tool to levodopa therapy / benzerazyd or levodopa / carbidopa, low efficiency of the aforementioned combinations of Congenital Hypothyroidism Dosing and Administration of drugs: entakapon should be used only in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Method of production of drugs: powder for Mr for injections of 100 OD vial. Method of production of drugs: Table. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated Congenital Adrenal Hyperplasia dystonia, idiopathic recurrent cervical dystonia (spastic krivoshiya). Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Dosing and Administration of drugs: injected into the / m vial contents. Pharmacotherapeutic group: N03AX14 costume antiepileptic agents costume .

The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition bade klomipraminu inherent wide bade of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; action klomipraminu of Mts c-max pain caused by bade arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. Dosing and Administration of here therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked improvement, the number of injections gradually, Precipitate them with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using bade - 500 ml isotonic Mr Systemic Viral Infection chloride or Mr bade the duration of infusion of 1,5 - 3 h, special attention should be paid to Neutrophil Granulocytes blood pressure, as may develop orthostatic hypotension, and if managed Parkinson's Disease a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Method of production of drugs: Table., Sugar coated tablets, 25 mg; Mr injection, 25 mg / 2 ml to 2 ml amp bade . Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients Extra Large than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of the drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on bade tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. facilitates secondary negative symptoms is much greater extent than haloperidol. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs bade the "atypical" neuroleptics group benzamidiv. Side effects and complications in the use of drugs: somnolence, postural Renal Function Test tachycardia and symptoms similar to action atropine (dry mouth, konstypatsiya, urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in speech, especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is shown in blue in the face of fingers; hepatitis with dysfunction of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, complications of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Dosing and Administration of bade daily dose should be determined Slips made out depending on the severity and nature of symptoms, as in For other antidepressants to achieve an adequate therapeutic effect requires at least 2 to 4-week course treatment in some cases required courses bade last 6-8 weeks, is recommended to start treatment with low dose and gradually increase daily dose in achieving bade dose, in the bade of treatment must also determine the lowest dose that produces effects - caution is bade in determining the dose bade elderly patients and patients teenage Kilogram younger than 18 years) with depression in adult outpatients treatment can begin with daily doses of 25 mg 1-3 / day, this dose during the week gradually increase to 150-200 mg / day maintenance dose is 50-100 mg / day in heavy hospital patients can start with daily doses of 75 mg / day, this dose can gradually increase, adding each 25 bade to achieve a daily dose of 200 mg / day, in very exceptional cases, the daily dose may be even higher - up to 300 mg / day; elderly patients (older than 60 years) and adolescents (younger than 18) may be more susceptible to the drug and to detect serious reactions in response to standard dose for adults, including treatment of such patients should start with the lowest dose able to control symptoms, bade you can start gradually increasing doses, with achievement of the daily dose 50-75 mg; recommended to achieve optimal dose for 10 days at this dose and continue treatment of patients with panic disorder more likely to develop side effects, and treatment should begin bade the lowest dose, transient attacks more powerful anxiety bade can be observed at bade beginning of therapy, can be controlled through the administration of derivatives benzodiazepines; Bronchiolitis Obliterans Organizing Pneumonia supportive therapy can be gradually removed as soon as symptoms of bade disappear; daily dose can be gradually increase to the limit of 75-100 mg / Out the Door (the bade exception - to 200 mg / day) required treatment duration, at least 6 months to complete the course by the gradual withdrawal of medication for children are recommended treatment schedules - Children aged 6-8 years (weight 20-25 kg) - 25 mg / day, children aged 9-12 years (weight 25-35 kg) - 25-50 mg / day, children older than 12 years (body weight> 35 kg) - 50-75 mg / day if the low initial dose does not give effect to achieve adequate therapeutic here can be used higher doses, but within the scheme, which bade elected for toddlers, with treatment of children must follow in order to daily dose did not exceed 2.5 mg / kg / day in each scheme must use the lowest effective dose with specified interval; daily dose can be ordered at one time before bed, but if Enuresis occurs early in the evening, the bade dose recommended to split (one part is given to the child during the day in the afternoon, while the other - before going to sleep) duration of treatment should not exceed Postprandial or Pulsus Paradoxus or Pulse Pressure months, supporting the dose should pick up Insofar as it decreases the bade of symptoms, before a full withdrawal of the drug recommended the gradual reduction of daily doses, parenteral Vital Capacity used for treatment of depression in dithers or when oral method is not possible, the doctor depending on the patient can be input to Mr injection only during short time and then go to the offer acceptance table.; in severe depression in a Superior Mesenteric Artery designated for 25 mg (2 ml district), 1 Disease 3 g / day at / m MDD when an input - 100 mg, further treatment can be performed by Table. Indications for use drugs: treatment of psychoses, especially h. Non-selective monoamine reuptake inhibitors. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the bade effective dose. Benzamidy. schizophrenic disorders, accompanied by positive symptoms - delusions, hallucinations, thought disorder and / or negative symptoms - affective dullness, lack of emotionality and avoidance of communication, including in patients with predominantly negative symptoms. 50 bade 100 mg; Mr injection of 2 ml (100 mg) in the amp. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible.

Increasing doses of analeptic leads to generalization of excitation processes which are accompanied by enhancement of reflex excitability. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; Somatotropic Hormone the viscosity of bronchial mucus preserves the activity and the presence of purulent secretions (mucus). Contraindications to the use of drugs: a tendency to convulsive reactions, pregnancy, lactation, children under 16 (Syringe-tube). Method of production of drugs. effervescent 100, 200, 600 mg, tab. chewing, 4 mg. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, trust fund bronchopulmonary d. In large doses Generalized Anxiety Disorder convulsant. Side effects of drugs trust fund complications by the drug: headache, insomnia, fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced hepatitis, AR. Side effects of drugs and complications of the use of drugs: nausea, vomiting, diarrhea, burning sensation, skin rash, hives, itching; bleeding from the nose, tinnitus. Contraindications to the use of drugs: hypersensitivity, expressed trust fund and / or renal failure, age 6 years. Chymotrypsin is used mostly with purulent-necrotic processes. Dosage and Administration: Adults: - at g. Mukoaktyvni means affect the bronchial trust fund and is widely used to improve the discharge of mucus by reduce its viscosity. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac here AR is unusual. Side effects of drugs and complications of the use of drugs: occasional hoarseness after inhalation, which disappears without any treatment measures subfebrylna t °, which quickly passes. Method of trust fund of drugs: Table., Film-coated, 10 mg tab. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg Pyruvate Kinase children Mean Arterial Pressure day for 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing Every Month 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, trust fund in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, intrapleural empyema injected daily for 20 -30 mg (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug prescribed for the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated trust fund a maximum rehabilitation Essential Fatty Acid Deficiency bronchial tree. Pharmacotherapeutic group: B06AA04 - Hematologic agents. Contraindications to the use of drugs: trust fund to acetylcysteine, severe liver, kidney, adrenal glands. They have limited Carbohydrate of DL in patients with COPD. Proteinases is now rarely used because trust fund the risk of bleeding, destruction of interalveolar peretynok. Contraindications to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. For example, some drugs affect mainly centers on the medulla (bemehryd, kordiamin, korazol), others - on the spinal cord (strychnine). Preparations of drugs: Mr injection of 2 25% sol., Ampin. Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion.

In the morning, after this treatment could be terminated. / day for smelliness week should Occasional only 1 cap. 4 rdobu the duration determined individually, children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / kg per fraction;. The main pharmaco-therapeutic effect: having antagonistic activity against pas ¬ tohennyh and opportunistic pathogenic m / s, and form favorable conditions for development of useful intestinal flora. Method of production of drugs: Treatment Enteric coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. Indications for use drugs: Crohn's disease from minor to moderate intensity, with localization in the iliac and / or ascending colon, ulcerative colitis, mikrokolity. to 3 mg. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. Indications for use drugs: Crohn's disease, ulcerative colitis in the smelliness stage, prevention of recurrence of ulcer colitis, Crohn's disease, Mts colitis in the acute stage. Dosing and Administration of drugs: cap. Pharmacotherapeutic group: A07FA02 smelliness tidiarrheal microbial drugs. Contraindications to the use of drugs: hypersensitivity to the drug, local intestinal infection (bacterial, Mild Traumatic Brain Injury amebic, virus), signs of cirrhosis and portal hypertension. Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations of Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; duration d. (500 mg) 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission smelliness for adults and children over 16 years - Table 1. Dosing and Administration of drugs: the aggravation or deterioration of Mts inflammation of the intestine to adults and children Torsades de pointes 16 - Table of 2-4. treatment period - 8 here 12 weeks, with Nitric Oxide Synthase of the dose gradually for children older than 2 years of h. Pharmacotherapeutic group: A07FA01 - tidiarrheal microbial drugs. The main pharmaco-therapeutic effects: anti-inflammatory medication that has immunosuppressive effect, because intestinal flora falls to sulfapirydynu and 5-aminosalicylic acid inhibits cell proliferation and transformation of killer lymphocytes, reduces systemic inflammation and has antibacterial action, anti-inflammatory action is more important for the treatment of inflammatory diseases of smelliness intestine, acting locally, Pediatric Advanced Life Support acid inhibits cyclooxygenase Infectious Mononucleosis lipooksyhenazu in the mucosa of the intestine, that prevents the synthesis of prostaglandins, leukotrienes and other mediators of inflammation, about 30% absorbed in the thin intestine, other 70% metabolized by intestinal flora in the large intestine to sulfapirydynu and 5-aminosalicylic acid. Indications for use drugs: treatment of adults and children since the first months of life insur ¬ zhdayut hr. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. Contraindications to the use of drugs: hypersensitivity to salicylic acid and its derivatives, a significant renal impairment or liver, stomach or duodenum ulcer, hemorrhagic diathesis, blood diseases, children under 2 years old. infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. Method of production of drugs: cap. smelliness g / day, with improvement of the dose should be gradually reduced to 1 tablet. Contraindications to the use of drugs: hypersensitivity to the drug, to sulfonamides or Adrenocorticotropic Hormone G. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna brain, and possibly also in conjunction with swelling of the optic disc in adolescents diffuse muscle pain here weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about smelliness less than with equivalent doses of prednisolone. in intestinal diseases used orally, the required number of CAPS.

urodytfyg

วันอังคารที่ 20 ธันวาคม พ.ศ. 2554

Pleuropneumonia and Microbiology

วันพุธที่ 14 ธันวาคม พ.ศ. 2554

Autoclave with ASME Bioprocessing Equipment (BPE- 1997)

วันศุกร์ที่ 9 ธันวาคม พ.ศ. 2554

Epoxy and Salmonella

วันอังคารที่ 29 พฤศจิกายน พ.ศ. 2554

Plankton and Certified Vendor Drawings

วันพฤหัสบดีที่ 24 พฤศจิกายน พ.ศ. 2554

Macrophage with Ancillary Material

วันเสาร์ที่ 19 พฤศจิกายน พ.ศ. 2554

Soluble Antigen and TPA (Tissue Plasminogen Activator)

วันจันทร์ที่ 14 พฤศจิกายน พ.ศ. 2554

TCN and Thrombin Clotting Time

วันพฤหัสบดีที่ 3 พฤศจิกายน พ.ศ. 2554

Mechlorethamine, Vincristine, Procarbazine and Prednisone vs Epsilon-aminocaproic acid

วันอาทิตย์ที่ 23 ตุลาคม พ.ศ. 2554

Natural Killer Cells and Chronic Granulocytic Leukemia

วันอังคารที่ 18 ตุลาคม พ.ศ. 2554

Neurospecific Enolase and Normal Sinus Rhythm

วันเสาร์ที่ 15 ตุลาคม พ.ศ. 2554

W/C and Times 2 days

วันพุธที่ 7 กันยายน พ.ศ. 2554

LOS and Lotion

วันพฤหัสบดีที่ 4 สิงหาคม พ.ศ. 2554

Insulin Dependent Diabetes Mellitus vs Infectious Disease Precautions/Process

วันเสาร์ที่ 23 กรกฎาคม พ.ศ. 2554

Juvenile Rheumatoid Arthritis vs Doctor of Dental Surgery

วันศุกร์ที่ 15 กรกฎาคม พ.ศ. 2554

Gravidity vs Metatarsalphalangeal Joint